• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    6.650 +1.300 (+24.30%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,314,193
    Open 5.350
    Bid (Size) 6.400 (900)
    Ask (Size) 6.500 (1,000)
    Prev. Close 5.350
    Today's Range 5.350 - 7.230
    52wk Range 4.300 - 20.75
    Shares Outstanding 45,711,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗
    Capricor said in early November that it expects to announce results from the HOPE-3 trial in the coming weeks. 
    Via Stocktwits
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill

    Performance

    YTD
    -55.5%
    -55.5%
    1 Month
    +2.2%
    +2.2%
    3 Month
    +5.1%
    +5.1%
    6 Month
    -34.9%
    -34.9%
    1 Year
    -66.1%
    -66.1%

    More News

    Read More
    News headline image
    Top movers in Monday's session ↗
    Via Chartmill
    ‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17% ↗
    Via Stocktwits
    Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection ↗
    Via Stocktwits
    Tesla Chair Declares Start Of 'Whole New Book' As Musk's 423 Million Share Award Is Locked In — All Hope Pinned On Robotaxi, Optimus ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Preview: Capricor Therapeutics's Earnings ↗
    Via Benzinga
    News headline image
    Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗
    Via Benzinga
    News headline image
    Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback ↗
    Via Stocktwits
    News headline image
    CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Capricor Stock Rises Pre-Market Over Fresh Hopes of Deramiocel Approval In Treating Genetic Disorder ↗
    Via Stocktwits
    News headline image
    Why Capricor Therapeutics Stock Is Surging Today ↗
    Via Benzinga
    News headline image
    Gapping stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    CAPRICOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Capricor Therapeutics, Inc. of the September 15th Deadline for the Class Action Lawsuit
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    CAPR DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 15 Deadline in Securities Class Action – CAPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
    Via NewMediaWire
    Topics Fraud Lawsuit

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 6.650
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 12/01/25 04:00 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 303.98M
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 304M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.